6505--Metformin 24HR SA Tablets PPV

The Department of Veterans Affairs National Acquisition Center is soliciting proposals for Metformin Hydrochloride 24-hour Sustained Action (SA) Tablets under solicitation 36E79725R0051. This procurement seeks to establish a pharmaceutical prime vendor contract for multiple package sizes of 500mg and 750mg Metformin tablets, with quantities ranging from 30 to 1,000 tablets per bottle. The contract will serve multiple federal agencies including the VA, Department of Defense, Indian Health Service, and Bureau of Prisons. Offerors must submit pricing for all line items across the base year and four one-year option periods, with pricing required to include a 0.5% Cost Recovery Fee and provision of a unique 11-digit National Drug Code number. The contract will be awarded on an aggregate basis, requiring compliance with FDA regulations, Letters of Commitment, and specific packaging and labeling requirements. Originally due July 28, 2025, the proposal submission deadline has been extended twice and is now August 25, 2025 at 2:30 PM Central Time.

This solicitation does not utilize any set-aside designations and is open to all qualified pharmaceutical manufacturers. The estimated annual usage ranges from approximately 11,000 to 370,000 bottles across different package sizes, indicating significant procurement volumes for this diabetes medication. The contract structure includes a base year with four one-year option periods, providing potential for a five-year total contract duration. Distribution will be handled through pharmaceutical prime vendors, suggesting a comprehensive supply chain management approach. No specific contract values are disclosed in the available documentation, and no current incumbents are identified in the solicitation materials.